- Slimming clinic
Albany Medical Centre
Assessment report published 30 October 2026
Contents
On this page
- Overview
- Learning culture
- Safe systems, pathways and transitions
- Safeguarding
- Involving people to manage risks
- Safe environments
- Safe and effective staffing
- Infection prevention and control
- Medicines optimisation
Safe
We looked for evidence that people were protected from abuse and avoidable harm.
At our last assessment, we rated this key question as good. At this assessment, the rating has remained the same.
We found breaches of regulation in relation to regulation 12 of the Health and Social Care Act 2008 (Regulated Activities), safe care and treatment. We have asked the provider for an action plan in response to the concerns found at this assessment.
This service scored 72 (out of 100) for this area. Find out what we look at when we assess this area and How we calculate these scores.
Learning culture
The registered provider had a proactive and positive culture of safety, based on openness and honesty. Lessons were learnt to continually identify and embed good practice.
People felt supported to raise concerns and felt staff treated them with compassion and understanding. Managers encouraged staff to raise concerns when things went wrong. The provider had processes for staff to report incidents, near misses and safety events. There was a system to record and investigate complaints, and when things went wrong, staff apologised and gave people support. Learning from incidents and complaints resulted in changes that improved care for others.
Safe systems, pathways and transitions
The registered provider worked with people and healthcare partners to establish and maintain safe systems of care, in which safety was managed or monitored. They made sure there was continuity of care, including providing information to patient’s NHS GP if they consented to this.
There were systems in place for processing information relating to new patients. The registered provider worked with other providers to deliver shared care and when patients moved between services. All patients were asked for consent to share details of their consultation and any medicines prescribed with their registered NHS GP on each occasion they used the registered provider. Before providing treatment, doctors at the registered provider ensured they had adequate knowledge of the patient’s health, any relevant test results and their medicines history.
Safeguarding
The registered provider worked with people and healthcare partners to understand what safeguarding meant and staff knew how to share concerns quickly and appropriately.
Safeguarding policies were in place and known to staff, who were appropriately trained in safeguarding procedures.
Involving people to manage risks
The registered provider did not always work well with people to understand and manage risks. In most circumstances, staff provided care to meet people’s needs that was safe, supportive and enabled people to do the things that mattered to them. However, although emergency equipment was available at the service, a medicine used in the case of anaphylaxis that was kept at the service had a use by date 3 weeks before the inspection and was therefore not safe to use.
Safe environments
The registered provider detected and controlled potential risks in the care environment. They made sure equipment, facilities and technology supported the delivery of safe care.
Contracts were in place to ensure the premises were maintained. Health and safety risk assessments and audits had been undertaken and risks identified had been addressed. There was a business continuity plan in place which was monitored and reviewed.
Safe and effective staffing
The registered provider made sure there were enough qualified, skilled and experienced staff, who received effective support, supervision and development.
We found training was up to date, learning needs and development of staff was managed appropriately, and staff were working within their agreed areas of competence. Safe recruitment practices were followed. The provider used ‘practicing privileges’ to grant permission to medical practitioners and other healthcare professionals to work at the registered provider without the need to register separately.
Infection prevention and control
The registered provider assessed and managed the risk of infection. They detected and controlled the risk of it spreading and shared concerns with appropriate agencies promptly.
All staff had had relevant training. Cleaning schedules were in place and followed. Risk assessments and audits were completed, and actions taken to mitigate risks.
Medicines optimisation
The service had effective systems and processes to support the safe use of medicines. Clinicians completed an assessment before starting treatment which considered people’s medical history, current medicines, physical health and individual risk factors. They followed defined treatment criteria and did not prescribe when a person’s health needs made treatment unsuitable. People received advice about diet, physical activity and other ways to manage their weight when medicines were not appropriate.
People were involved in decisions about their treatment. We saw evidence that clinicians discussed the expected benefits, possible side effects and available treatment options before prescribing. They obtained consent and provided information to help people use their medicines safely. This included practical support for people using injectable medicines and information about managing possible adverse effects.
The service reviewed people regularly and monitored their weight, body mass index (a screening tool that estimates your body fat based on your height and weight), blood pressure, response to treatment and side effects. Clinicians amended treatment when it was not effective, caused unacceptable adverse effects or the person had reached their treatment goal. Medicines formed part of a wider weight-management plan that included dietary and physical activity advice.
Medicines were stored securely, and the service monitored storage temperatures and maintained stock records. Prescribers recorded the medicines and quantities supplied, and the records reviewed did not show supplies exceeding 30 days. The provider also had medicines policies in place and had updated these to reflect its use of glucagon-like peptide-1 (GLP-1) medicines.
Clinicians encouraged people to consent to sharing prescribing information with their GP and sent clinic letters where consent was given. However, the service did not always clearly demonstrate how it assessed and managed the risks when people receiving treatment, including central nervous system (CNS) stimulant medicines that act as appetite suppressants, did not consent to GP contact.